Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-03-11

FDA Approved: ZIPRASIDONE HYDROCHLORIDE — Supplemental Application (Apotex Corp.)

View source ↗

Summary

FDA approved Apotex Corp.'s supplemental application for ziprasidone hydrochloride under an ANDA. This action supports a generic version of the antipsychotic fo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ziprasidone hydrochloride (generic) (Ziprasidone hydrochloride)

Snippet

SUPPL AP for ZIPRASIDONE HYDROCHLORIDE (ZIPRASIDONE HCL)